{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:43:21Z","timestamp":1740149001665,"version":"3.37.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A proportion of patients with the acute coronary syndrome (ACS) will suffer progressive remodeling of the left ventricular (LV). The aim was to screen for important biomarkers from a large-scale protein profiling in 420 ACS patients and define biomarkers associated with reduced LV function early and 1\u00a0year after the ACS. Transferrin receptor protein 1 and NT-proBNP were associated with LV function early and after 1\u00a0year, whereas osteopontin and soluble ST2 were associated with LV function in the early phase and, tissue-type plasminogen activator after 1\u00a0year. Fatty-acid-binding protein and galectin 3 were related to worse GLS but not to LVEF 1\u00a0year after the ACS. Proteins involved in remodeling and iron transport in cardiomyocytes were related to worse LV function after ACS. Biomarkers for energy metabolism and fibrosis were exclusively related to worse LV function by GLS. Studies on the functions of these proteins might add knowledge to the biological processes involved in heart failure in long term after ACS.<\/jats:p>","DOI":"10.1007\/s12265-022-10285-2","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T13:05:21Z","timestamp":1655816721000},"page":"244-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-8084","authenticated-orcid":false,"given":"Christina","family":"Christersson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Flachskampf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Lindhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertil","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agneta","family":"Siegbahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"10285_CR1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., Gonzalez-Juanatey, J. R., Harjola, V. P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G. M. C., Ruilope, L. M., Ruschitzka, F., \u2026 Group ESCSD. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 37, 2129\u20132200.","journal-title":"European Heart Journal"},{"key":"10285_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1161\/01.CIR.66.3.527","volume":"66","author":"PJ De Feyter","year":"1982","unstructured":"De Feyter, P. J., van Eenige, M. J., Dighton, D. H., Visser, F. C., de Jong, J., & Roos, J. P. (1982). Prognostic value of exercise testing, coronary angiography and left ventriculography 6\u20138 weeks after myocardial infarction. Circulation, 66, 527\u2013536.","journal-title":"Circulation"},{"key":"10285_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.7326\/0003-4819-134-6-200103200-00009","volume":"134","author":"SD Solomon","year":"2001","unstructured":"Solomon, S. D., Glynn, R. J., Greaves, S., Ajani, U., Rouleau, J. L., Menapace, F., Arnold, J. M., Hennekens, C., & Pfeffer, M. A. (2001). Recovery of ventricular function after myocardial infarction in the reperfusion era: The healing and early afterload reducing therapy study. Annals of Internal Medicine, 134, 451\u2013458.","journal-title":"Annals of Internal Medicine"},{"key":"10285_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jacc.2008.08.067","volume":"53","author":"JA Ezekowitz","year":"2009","unstructured":"Ezekowitz, J. A., Kaul, P., Bakal, J. A., Armstrong, P. W., Welsh, R. C., & McAlister, F. A. (2009). Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. Journal of the American College of Cardiology, 53, 13\u201320.","journal-title":"Journal of the American College of Cardiology"},{"key":"10285_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jchf.2014.10.007","volume":"3","author":"L Desta","year":"2015","unstructured":"Desta, L., Jernberg, T., Lofman, I., Hofman-Bang, C., Hagerman, I., Spaak, J., & Persson, H. (2015). Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART Registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies): A study of 199,851 patients admitted with index acute myocardial infarctions, 1996 to 2008. JACC Heart Failure, 3, 234\u2013242.","journal-title":"JACC Heart Failure"},{"key":"10285_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrm2970","volume":"11","author":"P Vandenabeele","year":"2010","unstructured":"Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., & Kroemer, G. (2010). Molecular mechanisms of necroptosis: An ordered cellular explosion. Nature Reviews Molecular Cell Biology, 11, 700\u2013714.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10285_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2174\/1566524033361537","volume":"3","author":"A Diwan","year":"2003","unstructured":"Diwan, A., Tran, T., Misra, A., & Mann, D. L. (2003). Inflammatory mediators and the failing heart: A translational approach. Current Molecular Medicine, 3, 161\u2013182.","journal-title":"Current Molecular Medicine"},{"key":"10285_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11897-010-0044-2","volume":"8","author":"JH Flores-Arredondo","year":"2011","unstructured":"Flores-Arredondo, J. H., Garcia-Rivas, G., & Torre-Amione, G. (2011). Immune modulation in heart failure: Past challenges and future hopes. Current Heart Failure Reports, 8, 28\u201337.","journal-title":"Current Heart Failure Reports"},{"key":"10285_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","volume":"87","author":"FG Spinale","year":"2007","unstructured":"Spinale, F. G. (2007). Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiological Reviews, 87, 1285\u20131342.","journal-title":"Physiological Reviews"},{"key":"10285_CR10","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","volume":"67","author":"PC Westman","year":"2016","unstructured":"Westman, P. C., Lipinski, M. J., Luger, D., Waksman, R., Bonow, R. O., Wu, E., & Epstein, S. E. (2016). Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction. Journal of the American College of Cardiology, 67, 2050\u20132060.","journal-title":"Journal of the American College of Cardiology"},{"key":"10285_CR11","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/01.RES.0000261924.76669.36","volume":"100","author":"Y Matsui","year":"2007","unstructured":"Matsui, Y., Takagi, H., Qu, X., Abdellatif, M., Sakoda, H., Asano, T., Levine, B., & Sadoshima, J. (2007). Distinct roles of autophagy in the heart during ischemia and reperfusion: Roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circulation Research, 100, 914\u2013922.","journal-title":"Circulation Research"},{"key":"10285_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm1574","volume":"13","author":"A Nakai","year":"2007","unstructured":"Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., Nishida, K., Hori, M., Mizushima, N., & Otsu, K. (2007). The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nature Medicine, 13, 619\u2013624.","journal-title":"Nature Medicine"},{"key":"10285_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ejhf.431","volume":"18","author":"MM Chan","year":"2016","unstructured":"Chan, M. M., Santhanakrishnan, R., Chong, J. P., Chen, Z., Tai, B. C., Liew, O. W., Ng, T. P., Ling, L. H., Sim, D., Leong, K. T., Yeo, P. S., Ong, H. Y., Jaufeerally, F., Wong, R. C., Chai, P., Low, A. F., Richards, A. M., & Lam, C. S. (2016). Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction. European Journal of Heart Failure, 18, 81\u201388.","journal-title":"European Journal of Heart Failure"},{"key":"10285_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cardfail.2015.07.017","volume":"22","author":"WL Miller","year":"2016","unstructured":"Miller, W. L., Saenger, A. K., Grill, D. E., Slusser, J. P., Bayes-Genis, A., & Jaffe, A. S. (2016). Prognostic value of serial measurements of soluble suppression of tumorigenicity 2 and galectin-3 in ambulatory patients with chronic heart failure. Journal of Cardiac Failure, 22, 249\u2013255.","journal-title":"Journal of Cardiac Failure"},{"key":"10285_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2217\/bmm.15.12","volume":"9","author":"R Zhang","year":"2015","unstructured":"Zhang, R., Zhang, Y., An, T., Guo, X., Yin, S., Wang, Y., Januzzi, J. L., Cappola, T. P., & Zhang, J. (2015). Prognostic value of sST2 and galectin-3 for death relative to renal function in patients hospitalized for heart failure. Biomarkers in Medicine, 9, 433\u2013441.","journal-title":"Biomarkers in Medicine"},{"key":"10285_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ejhf.980","volume":"20","author":"M Stenemo","year":"2018","unstructured":"Stenemo, M., Nowak, C., Byberg, L., Sundstrom, J., Giedraitis, V., Lind, L., Ingelsson, E., Fall, T., & Arnlov, J. (2018). Circulating proteins as predictors of incident heart failure in the elderly. European Journal of Heart Failure, 20, 55\u201362.","journal-title":"European Journal of Heart Failure"},{"key":"10285_CR17","doi-asserted-by":"crossref","unstructured":"Aimo, A., Januzzi, J. L., Jr., Vergaro, G., Richards, A. M., Lam, C. S. P., Latini, R., Anand, I. S., Cohn, J. N., Ueland, T., Gullestad, L., Aukrust, P., Brunner-La Rocca, H. P., Bayes-Genis, A., Lupon, J., de Boer, R. A., Takeishi, Y., Egstrup, M., Gustafsson, I., Gaggin, H. K., Eggers, K. M., Huber, K., Gamble, G. D., Ling, L. H., Leong, K. T. G., Yeo, P. S. D., Ong, H. Y., Jaufeerally, F., Ng, T. P., Troughton, R., Doughty, R. N., Passino, C., Emdin, M. (2020). Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T. European Journal of Heart Failure,\u00a022(11), 2078\u20132088","DOI":"10.1002\/ejhf.1701"},{"key":"10285_CR18","doi-asserted-by":"crossref","unstructured":"Tromp, J., Boerman, L. M., Sama, I. E., Maass, S., Maduro, J. H., Hummel, Y. M., Berger, M. Y., de Bock, G. H., Gietema, J. A., Berendsen, A. J., van der Meer, P. (2020). Long-term survivors of early breast cancer treated with chemotherapy are characterized by a pro-inflammatory biomarker profile compared to matched controls. European Journal of Heart Failure\u00a022(7), 1239\u20131246","DOI":"10.1002\/ejhf.1758"},{"key":"10285_CR19","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/jch.12849","volume":"18","author":"JC Rodrigues","year":"2016","unstructured":"Rodrigues, J. C., Rohan, S., Dastidar, A. G., Trickey, A., Szantho, G., Ratcliffe, L. E., Burchell, A. E., Hart, E. C., Bucciarelli-Ducci, C., Hamilton, M. C., Nightingale, A. K., Paton, J. F., Manghat, N. E., & MacIver, D. H. (2016). The Relationship between left ventricular wall thickness, myocardial shortening, and ejection fraction in hypertensive heart disease: Insights from cardiac magnetic resonance imaging. Journal of Clinical Hypertension (Greenwich), 18, 1119\u20131127.","journal-title":"Journal of Clinical Hypertension (Greenwich)"},{"key":"10285_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/hc0102.101396","volume":"105","author":"NL Greenberg","year":"2002","unstructured":"Greenberg, N. L., Firstenberg, M. S., Castro, P. L., Main, M., Travaglini, A., Odabashian, J. A., Drinko, J. K., Rodriguez, L. L., Thomas, J. D., & Garcia, M. J. (2002). Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility. Circulation, 105, 99\u2013105.","journal-title":"Circulation"},{"key":"10285_CR21","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/ehjci\/jex260","volume":"19","author":"T Baron","year":"2018","unstructured":"Baron, T., Christersson, C., Hjorthen, G., Hedin, E. M., & Flachskampf, F. A. (2018). Changes in global longitudinal strain and left ventricular ejection fraction during the first year after myocardial infarction: Results from a large consecutive cohort. European Heart Journal Cardiovascular Imaging, 19, 1165\u20131173.","journal-title":"European Heart Journal Cardiovascular Imaging"},{"key":"10285_CR22","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1136\/heartjnl-2014-305538","volume":"100","author":"K Kalam","year":"2014","unstructured":"Kalam, K., Otahal, P., & Marwick, T. H. (2014). Prognostic implications of global LV dysfunction: A systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart, 100, 1673\u20131680.","journal-title":"Heart"},{"key":"10285_CR23","first-page":"260","volume":"11","author":"E Potter","year":"2018","unstructured":"Potter, E., & Marwick, T. H. (2018). Assessment of left ventricular function by echocardiography: The case for routinely adding global longitudinal strain to ejection fraction. JACC: Cardiovascular Imaging, 11, 260\u2013274.","journal-title":"JACC: Cardiovascular Imaging"},{"key":"10285_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/03009734.2017.1407849","volume":"122","author":"C Christersson","year":"2017","unstructured":"Christersson, C., Lindahl, B., Berglund, L., Siegbahn, A., & Oldgren, J. (2017). The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients. Upsala Journal of Medical Science, 122, 224\u2013233.","journal-title":"Upsala Journal of Medical Science"},{"key":"10285_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.thromres.2018.10.011","volume":"172","author":"A Kulasingam","year":"2018","unstructured":"Kulasingam, A., Hvas, A. M., Grove, E. L., Funck, K. L., & Kristensen, S. D. (2018). Detection of biomarkers using a novel proximity extension assay in patients with ST-elevation myocardial infarction. Thrombosis Research, 172, 21\u201328.","journal-title":"Thrombosis Research"},{"key":"10285_CR26","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1093\/eurheartj\/ehy421","volume":"39","author":"BT Santema","year":"2018","unstructured":"Santema, B. T., Kloosterman, M., Van Gelder, I. C., Mordi, I., Lang, C. C., Lam, C. S. P., Anker, S. D., Cleland, J. G., Dickstein, K., Filippatos, G., Van der Harst, P., Hillege, H. L., Ter Maaten, J. M., Metra, M., Ng, L. L., Ponikowski, P., Samani, N. J., Van Veldhuisen, D. J., Zwinderman, A. H., \u2026 Voors, A. A. (2018). Comparing biomarker profiles of patients with heart failure: Atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction. European Heart Journal, 39, 3867\u20133875.","journal-title":"European Heart Journal"},{"key":"10285_CR27","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson, E., Lundberg, M., Holmquist, G., Bjorkesten, J., Thorsen, S. B., Ekman, D., Eriksson, A., Rennel Dickens, E., Ohlsson, S., Edfeldt, G., Andersson, A. C., Lindstedt, P., Stenvang, J., Gullberg, M., & Fredriksson, S. (2014). Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE, 9, e95192.","journal-title":"PLoS ONE"},{"key":"10285_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., Lancellotti, P., Muraru, D., Picard, M. H., Rietzschel, E. R., Rudski, L., Spencer, K. T., Tsang, W., & Voigt, J. U. (2015). Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal Cardiovascular Imaging, 16, 233\u2013270.","journal-title":"European Heart Journal Cardiovascular Imaging"},{"key":"10285_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","volume":"16","author":"JU Voigt","year":"2015","unstructured":"Voigt, J. U., Pedrizzetti, G., Lysyansky, P., Marwick, T. H., Houle, H., Baumann, R., Pedri, S., Ito, Y., Abe, Y., Metz, S., Song, J. H., Hamilton, J., Sengupta, P. P., Kolias, T. J., d\u2019Hooge, J., Aurigemma, G. P., Thomas, J. D., & Badano, L. P. (2015). Definitions for a common standard for 2D speckle tracking echocardiography: Consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging. European Heart Journal Cardiovascular Imaging, 16, 1\u201311.","journal-title":"European Heart Journal Cardiovascular Imaging"},{"key":"10285_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","volume":"30","author":"IR White","year":"2011","unstructured":"White, I. R., Royston, P., & Wood, A. M. (2011). Multiple imputation using chained equations: Issues and guidance for practice. Statistics in Medicine, 30, 377\u2013399.","journal-title":"Statistics in Medicine"},{"key":"10285_CR31","volume-title":"Resampling-based multiple testing: Examples and methods for p-value adjustment","author":"SS Westfall PaY","year":"1993","unstructured":"Westfall PaY, S. S. (1993). Resampling-based multiple testing: Examples and methods for p-value adjustment. John Wiley & Sons."},{"key":"10285_CR32","unstructured":"Kirasich, K., Smith, T., and Sadler, B. (2018). Random forest vs logistic regression: Binary classification for heterogeneous datasets. SMU Data Science Review, 1"},{"key":"10285_CR33","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ejhf.754","volume":"19","author":"AD DeVore","year":"2017","unstructured":"DeVore, A. D., McNulty, S., Alenezi, F., Ersboll, M., Vader, J. M., Oh, J. K., Lin, G., Redfield, M. M., Lewis, G., Semigran, M. J., Anstrom, K. J., Hernandez, A. F., & Velazquez, E. J. (2017). Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: Insights from the RELAX trial. European Journal of Heart Failure, 19, 893\u2013900.","journal-title":"European Journal of Heart Failure"},{"key":"10285_CR34","doi-asserted-by":"crossref","unstructured":"Aleksova, A., Paldino, A., Beltrami, A. P., Padoan, L., Iacoviello, M., Sinagra, G., Emdin, M., Maisel, A. S. (2019). Cardiac biomarkers in the emergency department: The role of soluble ST2 (sST2) in acute heart failure and acute coronary syndrome-there is meat on the bone. Journal of Clinical Medicine,\u00a08(2), 270","DOI":"10.3390\/jcm8020270"},{"key":"10285_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2014.09.014","volume":"118","author":"M Singh","year":"2014","unstructured":"Singh, M., Dalal, S., & Singh, K. (2014). Osteopontin: At the cross-roads of myocyte survival and myocardial function. Life Sciences, 118, 1\u20136.","journal-title":"Life Sciences"},{"key":"10285_CR36","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/01.HYP.33.2.663","volume":"33","author":"K Singh","year":"1999","unstructured":"Singh, K., Sirokman, G., Communal, C., Robinson, K. G., Conrad, C. H., Brooks, W. W., Bing, O. H., & Colucci, W. S. (1999). Myocardial osteopontin expression coincides with the development of heart failure. Hypertension, 33, 663\u2013670.","journal-title":"Hypertension"},{"key":"10285_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S1388-9842(01)00237-9","volume":"4","author":"P Stawowy","year":"2002","unstructured":"Stawowy, P., Blaschke, F., Pfautsch, P., Goetze, S., Lippek, F., Wollert-Wulf, B., Fleck, E., & Graf, K. (2002). Increased myocardial expression of osteopontin in patients with advanced heart failure. European Journal of Heart Failure, 4, 139\u2013146.","journal-title":"European Journal of Heart Failure"},{"key":"10285_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCHEARTFAILURE.107.746172","volume":"1","author":"M Rosenberg","year":"2008","unstructured":"Rosenberg, M., Zugck, C., Nelles, M., Juenger, C., Frank, D., Remppis, A., Giannitsis, E., Katus, H. A., & Frey, N. (2008). Osteopontin, a new prognostic biomarker in patients with chronic heart failure. Circulation. Heart Failure, 1, 43\u201349.","journal-title":"Circulation. Heart Failure"},{"key":"10285_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.lab.2004.08.007","volume":"145","author":"C Suezawa","year":"2005","unstructured":"Suezawa, C., Kusachi, S., Murakami, T., Toeda, K., Hirohata, S., Nakamura, K., Yamamoto, K., Koten, K., Miyoshi, T., & Shiratori, Y. (2005). Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: Correlation with left-ventricular volume and function. Journal of Laboratory and Clinical Medicine, 145, 33\u201340.","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10285_CR40","doi-asserted-by":"crossref","unstructured":"Tromp, J., Khan, M. A., Klip, I. T., Meyer, S., de Boer, R. A., Jaarsma, T., Hillege, H., van Veldhuisen, D. J., van der Meer, P., Voors, A. A. (2017). Biomarker profiles in heart failure patients with preserved and reduced ejection fraction. Journal of the American Heart Association, 6(4), e003989","DOI":"10.1161\/JAHA.116.003989"},{"key":"10285_CR41","doi-asserted-by":"publisher","first-page":"21613","DOI":"10.1002\/jcp.28820","volume":"234","author":"A Paterek","year":"2019","unstructured":"Paterek, A., Mackiewicz, U., & Maczewski, M. (2019). Iron and the heart: A paradigm shift from systemic to cardiomyocyte abnormalities. Journal of Cellular Physiology, 234, 21613\u201321629.","journal-title":"Journal of Cellular Physiology"},{"key":"10285_CR42","first-page":"362","volume":"38","author":"S Haddad","year":"2017","unstructured":"Haddad, S., Wang, Y., Galy, B., Korf-Klingebiel, M., Hirsch, V., Baru, A. M., Rostami, F., Reboll, M. R., Heineke, J., Flogel, U., Groos, S., Renner, A., Toischer, K., Zimmermann, F., Engeli, S., Jordan, J., Bauersachs, J., Hentze, M. W., Wollert, K. C., & Kempf, T. (2017). Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. European Heart Journal, 38, 362\u2013372.","journal-title":"European Heart Journal"},{"key":"10285_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cardiores.2006.02.025","volume":"70","author":"JL Zweier","year":"2006","unstructured":"Zweier, J. L., & Talukder, M. A. (2006). The role of oxidants and free radicals in reperfusion injury. Cardiovascular Research, 70, 181\u2013190.","journal-title":"Cardiovascular Research"},{"key":"10285_CR44","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","volume":"35","author":"EA Jankowska","year":"2014","unstructured":"Jankowska, E. A., Kasztura, M., Sokolski, M., Bronisz, M., Nawrocka, S., Oleskowska-Florek, W., Zymlinski, R., Biegus, J., Siwolowski, P., Banasiak, W., Anker, S. D., Filippatos, G., Cleland, J. G., & Ponikowski, P. (2014). Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure. European Heart Journal, 35, 2468\u20132476.","journal-title":"European Heart Journal"},{"key":"10285_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s00395-020-0782-6","volume":"115","author":"B Behrouzi","year":"2020","unstructured":"Behrouzi, B., Weyers, J. J., Qi, X., Barry, J., Rabadia, V., Manca, D., Connelly, J., Spino, M., Wood, J. C., Strauss, B. H., Wright, G. A., & Ghugre, N. R. (2020). Action of iron chelator on intramyocardial hemorrhage and cardiac remodeling following acute myocardial infarction. Basic Research in Cardiology, 115, 24.","journal-title":"Basic Research in Cardiology"},{"key":"10285_CR46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/ehjci\/jey101","volume":"20","author":"SJ Reinstadler","year":"2019","unstructured":"Reinstadler, S. J., Stiermaier, T., Reindl, M., Feistritzer, H. J., Fuernau, G., Eitel, C., Desch, S., Klug, G., Thiele, H., Metzler, B., & Eitel, I. (2019). Intramyocardial haemorrhage and prognosis after ST-elevation myocardial infarction. European Heart Journal Cardiovascular Imaging, 20, 138\u2013146.","journal-title":"European Heart Journal Cardiovascular Imaging"},{"key":"10285_CR47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcard.2011.08.006","volume":"159","author":"P Leszek","year":"2012","unstructured":"Leszek, P., Sochanowicz, B., Szperl, M., Kolsut, P., Brzoska, K., Piotrowski, W., Rywik, T. M., Danko, B., Polkowska-Motrenko, H., Rozanski, J. M., & Kruszewski, M. (2012). Myocardial iron homeostasis in advanced chronic heart failure patients. International Journal of Cardiology, 159, 47\u201352.","journal-title":"International Journal of Cardiology"},{"key":"10285_CR48","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s11427-016-0131-4","volume":"59","author":"JF Pei","year":"2016","unstructured":"Pei, J. F., Yan, Y. F., Tang, X., Zhang, Y., Cui, S. S., Zhang, Z. Q., Chen, H. Z., & Liu, D. P. (2016). Human paraoxonase gene cluster overexpression alleviates angiotensin II-induced cardiac hypertrophy in mice. Science China Life Sciences, 59, 1115\u20131122.","journal-title":"Science China Life Sciences"},{"key":"10285_CR49","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1093\/eurheartj\/ehz680","volume":"40","author":"HH van der Wal","year":"2019","unstructured":"van der Wal, H. H., Grote Beverborg, N., Dickstein, K., Anker, S. D., Lang, C. C., Ng, L. L., van Veldhuisen, D. J., Voors, A. A., & van der Meer, P. (2019). Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use. European Heart Journal, 40, 3616\u20133625.","journal-title":"European Heart Journal"},{"key":"10285_CR50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/ejhf.49","volume":"16","author":"Y Borne","year":"2014","unstructured":"Borne, Y., Persson, M., Melander, O., Smith, J. G., & Engstrom, G. (2014). Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation. European Journal of Heart Failure, 16, 377\u2013383.","journal-title":"European Journal of Heart Failure"},{"key":"10285_CR51","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1182\/blood-2002-03-0778","volume":"100","author":"AE May","year":"2002","unstructured":"May, A. E., Schmidt, R., Kanse, S. M., Chavakis, T., Stephens, R. W., Schomig, A., Preissner, K. T., & Neumann, F. J. (2002). Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction. Blood, 100, 3611\u20133617.","journal-title":"Blood"},{"key":"10285_CR52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jchf.2016.12.008","volume":"5","author":"L Koller","year":"2017","unstructured":"Koller, L., Stojkovic, S., Richter, B., Sulzgruber, P., Potolidis, C., Liebhart, F., Mortl, D., Berger, R., Goliasch, G., Wojta, J., Hulsmann, M., & Niessner, A. (2017). Soluble urokinase-type plasminogen activator receptor improves risk prediction in patients with chronic heart failure. JACC Heart Failure, 5, 268\u2013277.","journal-title":"JACC Heart Failure"},{"key":"10285_CR53","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1055\/s-0039-1696973","volume":"119","author":"VJ van den Berg","year":"2019","unstructured":"van den Berg, V. J., Bouwens, E., Umans, V., de Maat, M., Manintveld, O. C., Caliskan, K., Constantinescu, A. A., Mouthaan, H., Cornel, J. H., Baart, S., Akkerhuis, K. M., Boersma, E., & Kardys, I. (2019). Longitudinally measured fibrinolysis factors are strong predictors of clinical outcome in patients with chronic heart failure: The BIO-SHiFT Study. Thrombosis and Haemostasis, 119, 1947\u20131955.","journal-title":"Thrombosis and Haemostasis"},{"key":"10285_CR54","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1160\/TH16-08-0600","volume":"117","author":"MP Winter","year":"2017","unstructured":"Winter, M. P., Kleber, M. E., Koller, L., Sulzgruber, P., Scharnagl, H., Delgado, G., Goliasch, G., Marz, W., & Niessner, A. (2017). Prognostic significance of tPA\/PAI-1 complex in patients with heart failure and preserved ejection fraction. Thrombosis and Haemostasis, 117, 471\u2013478.","journal-title":"Thrombosis and Haemostasis"},{"key":"10285_CR55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijcard.2018.07.130","volume":"274","author":"B Popovic","year":"2019","unstructured":"Popovic, B., Zannad, F., Louis, H., Clerc-Urmes, I., Lakomy, C., Gibot, S., Denis, C. V., Lacolley, P., & Regnault, V. (2019). Endothelial-driven increase in plasma thrombin generation characterising a new hypercoagulable phenotype in acute heart failure. International Journal of Cardiology, 274, 195\u2013201.","journal-title":"International Journal of Cardiology"},{"key":"10285_CR56","doi-asserted-by":"crossref","unstructured":"Anzai, A., Ko, S., Fukuda, K. (2022). Immune and inflammatory networks in myocardial infarction: Current research and its potential implications for the clinic. International Journal of Molecular Sciences,\u00a023(9), 5214.","DOI":"10.3390\/ijms23095214"},{"key":"10285_CR57","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/nm.3284","volume":"19","author":"Y Zouggari","year":"2013","unstructured":"Zouggari, Y., Ait-Oufella, H., Bonnin, P., Simon, T., Sage, A. P., Guerin, C., Vilar, J., Caligiuri, G., Tsiantoulas, D., Laurans, L., Dumeau, E., Kotti, S., Bruneval, P., Charo, I. F., Binder, C. J., Danchin, N., Tedgui, A., Tedder, T. F., Silvestre, J. S., & Mallat, Z. (2013). B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nature Medicine, 19, 1273\u20131280.","journal-title":"Nature Medicine"},{"key":"10285_CR58","doi-asserted-by":"crossref","unstructured":"Rezar, R., Jirak, P., Gschwandtner, M., Derler, R., Felder, T. K., Haslinger, M., Kopp, K., Seelmaier, C., Granitz, C., Hoppe, U. C., Lichtenauer, M. (2020). Heart-type fatty acid-binding protein (H-FABP) and its role as a biomarker in heart failure: what do we know so far? Journal of Clinical Medicine, 9(1), 164.","DOI":"10.3390\/jcm9010164"},{"key":"10285_CR59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jacc.2012.08.1003","volume":"61","author":"F Varrone","year":"2013","unstructured":"Varrone, F., Gargano, B., Carullo, P., Di Silvestre, D., De Palma, A., Grasso, L., Di Somma, C., Mauri, P., Benazzi, L., Franzone, A., Jotti, G. S., Bang, M. L., Esposito, G., Colao, A., Condorelli, G., & Catalucci, D. (2013). The circulating level of FABP3 is an indirect biomarker of microRNA-1. Journal of the American College of Cardiology, 61, 88\u201395.","journal-title":"Journal of the American College of Cardiology"},{"key":"10285_CR60","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/1440-1681.13048","volume":"46","author":"X Zhong","year":"2019","unstructured":"Zhong, X., Qian, X., Chen, G., & Song, X. (2019). The role of galectin-3 in heart failure and cardiovascular disease. Clinical and Experimental Pharmacology and Physiology, 46, 197\u2013203.","journal-title":"Clinical and Experimental Pharmacology and Physiology"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-022-10285-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-022-10285-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-022-10285-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T22:12:11Z","timestamp":1677017531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-022-10285-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10285"],"URL":"https:\/\/doi.org\/10.1007\/s12265-022-10285-2","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"type":"print","value":"1937-5387"},{"type":"electronic","value":"1937-5395"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"assertion":[{"value":"8 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration. The study was approved by the local ethics committee, (Log No. 2009\/210). All patients signed a written informed consent before inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"AS had consulting fees from Olink Proteomics, Uppsala, Sweden. The Olink Proteomics had no input on the study design, analyses, interpretation, or manuscript preparation. All other authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}